anthrax Tangen Biosciences Receives Additional $3.3M From BARDA The added funds will be used by Tangen to develop a molecular diagnostic platform to detect anthrax in the bloodstream and develop infectious disease tests. BARDA Contract Win, Unprecedented CMS Incentive Expected to Catalyze T2 Biosystems Growth Premium While the news of the BARDA contract drove a surge in T2's stock price, it was last month's NTAP decision that has company officials and analysts encouraged. Tangen Biosciences Developing Lab-on-a-Disc Isothermal MDx for Point of Care Premium The Branford, Connecticut-based startup plans to seek US Food and Drug Administration clearance for and launch its instrument and first assays in 2021. Anthrax Genome From Autopsy Samples Offers Insights Into 1970s Soviet Biowarfare Program By sequencing autopsy samples linked to an anthrax outbreak in 1979, investigators got a glimpse at Bacillus anthracis spores from a USSR production facility. New Anthrax-Causing Clade Uncovered by Sequencing Researchers identified a form of Bacillus cereus from wild and domestic animals in West and Central Africa that contains virulence plasmids found in B. anthracis. Nov 4, 2014 Accelerate Dx, CDC Collaborate on Early Detection of Antibiotic-Resistant Pathogens Nov 20, 2012 Structural Genomics Consortia Land up to $52M from NIAID Dec 8, 2011 Idaho Tech's PCR-Based Biothreat Detection System Wins AOAC Certification Premium Aug 10, 2011 Eureka Genomics Wins DHS Anthrax Detection Grant Mar 8, 2011 Study Highlights Genomic Contributions to Amerithrax Investigation Feb 10, 2011 Akonni Biosystems Licenses USAMRIID IP to Develop Molecular Tests for Biothreat Agents Premium Mar 18, 2010 NIH Seeks to Outlicense Peptide Nucleic Acid Tech to Visualize DNA in Dx Apps Premium Breaking News FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.